Treatment outcome of personality disorders

Canadian Journal of Psychiatry

Volumn 43, Issue 3, 1998, Pages 237-250

  Sanislow, Charles A ^a   McGlashan, Thomas H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axis II; Functioning; Outcome; Personality disorders; Remission; Stability; Symptomatic behaviours; Symptoms; Treatment outcome

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; DISEASE COURSE; HUMAN; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REMISSION; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031759848     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379804300302     Document Type: Review

References (112)

1. American Psychiatric Assocation. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington (DC): American Psychiatric Press; 1980.
2. Heatherton TF, Weinberger JL, editors. Can personality change? Washington (DC): American Psychological Association Press; 1994.
3. Endicott J, Shea MT. Measurement of change in personality disorders. Psychopharmacol Bull 1989;25:572-7.
4. Lopez-Ibor JJ. The concept and boundaries of personality disorders. Am J Psychiatry 1997;154:21-5.
5. Paris J. The treatment of borderline personality disorder in light of the research on its long term outcome. Can J Psychiatry 1993;38(1 Suppl):28S-34S.
6. Stone MH. The course of borderline personality disorder. Annual Review of Psychiatry 1989;8:103-22.
7. Robins LN. Deviant children grown up. Baltimore (MD): Williams and Wilkin; 1966.
8. Grinker RR, Werble B, Drye RC. The borderline syndrome. New York: Basic Books; 1968.
9. Werble B. Second follow-up study of borderline patients. Arch Gen Psychiatry 1970;23:3-7.
10. Maddocks PD. A five year follow-up of untreated psychopaths. Br J Psychiatry 1970;116:511-5.
11. Carpenter WT, Gunderson JG. Five year follow-up comparison of borderline and schizophrenic patients. Compr Psychiatry 1977;18:567-71.
12. Carpenter WT, Gunderson JG, Strauss JS. Considerations of the borderline syndrome: a longitudinal comparative study of borderline and schizophrenic patients. In: Hartocollis P, editor. Borderline personality disorders: the concept, the syndrome, the patient. New York: International Universities Press; 1977. p 223-54.
13. Gunderson JG, Carpenter WT, Strauss JS. Borderline and schizophrenic patients: a comparative study. Am J Psychiatry 1975;132:1257-64.
14. Skodol AE, Buckley P, Charles E. Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality disorder? J Nerv Ment Dis 1980;171:405-10.
15. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am 1981;4:25-46.
16. Pope HG, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. The validity of the DSM-III borderline personality disorder. Arch Gen Psychiatry 1983;40:23-30.
17. Copas JB, O'Brien MO, Roberst J, Whiteley JS. Treatment outcome in personality disorder: the effect of social, psychological, and behavioural variables. Personality and Individual Differences 1984;5:565-73.
18. Barasch A, Frances A, Hurt S, Clarkin J, Cohen S. The stability and distinctness of borderline personality disorder. Am J Psychiatry 1985;142:1484-6.
19. Perry JC. Depression in borderline personality disorder: lifetime prevalence at interview and longitudinal course of the symptoms. Am J Psychiatry 1985;142:15-21.
20. Perry JC. A prospective study of life stress, defenses, psychotic symptoms, and depression in borderline and antisocial personality disorders and bipolar type II affective disorder. J Personal Disord 1988;4:273-89.
21. Perry JC, Cooper SH. Psychodynamics, symptoms, and outcome in borderline personality disorders and bipolar type II affective disorder. In: McGlashan TH, editor. The borderline: current empirical research. Washington (DC): American Psychiatric Press; 1985. p 19-41
22. Plakun EM, Burkhardt PE, Muller JP. Fourteen year follow-up of borderline and schizotypal personality disorders. Compr Psychiatry 1985;26:448-55.
23. Plakun EM. Narcissistic personality disorder a validity study and comparison to borderline personality disorder. Psychiatr Clin North Am 1989;12:603-20.
24. Plakun EM. Prediction of outcome in borderline personality disorder. J Personal Disord 1991;5:93-101.
25. McGlashan TH. The Chestnut Lodge follow-up study: part I. Follow-up methodology and study sample. Arch Gen Psychiatry 1984;41:573-85.
26. McGlashan TH. The Chestnut Lodge follow-up study: part III. Long-term outcome of borderline personalities. Arch Gen Psychiatry 1986;43:20-30.
27. Bardenstein KK, McGlashan TH. The natural history of a residentially treated borderline sample: gender differences. J Personal Disord 1989;3:69-83.
28. McGlashan TH. Schizotypal personality disorder. Arch Gen Psychiatry 1986;43:329-34.
29. Modestin J, Villiger C. Follow-up study on borderline versus non-borderline personality disorders. Compr Psychiatry 1987;28:530-5.
30. Paris J, Brown R, Nowlis D. Long-term follow-up of borderline patients in a general hospital. Compr Psychiatry 1987;28:530-5.
31. Paris J, Nowlis D, Brown R, Developmental factors in the outcome of borderline personality disorder. Compr Psychiatry 1988;29:147-50.
32. Stone MH. Psychotherapy of borderline patients in light of long-term follow up. Bull Menniger Clin 1987;51:231-47.
33. Stone MH, Hurt SW, Stone DK. The PI-500: long-term follow-up of borderline inpatients meeting DSM-III criteria: part I. Global outcome. J Personal Disord 1987;1:291-8.
34. Tucker L, Bauer SF, Wagner S, Harlam D, Sher I. Long-term hospitalization of borderline patients: a descriptive outcome study. Am J Psychiatry 1987;144:1443-8.
35. Costa FT, McCrae RR. Personality in adulthood: a six year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Personal Soc Psychol 1988;54:853-63.
36. Hart SD, Kropp PR, Hare RD. Performance of male psychopaths following conditional release from prison. J Consult Clin Psychol 1985;56:227-32.
37. Serin RC, Peters RD, Barbaree HE. Predictors of psychopathy and release outcome in a criminal population. Psychological Assessment 1990;2:419-22.
38. Silk KR, Lohr NE, Ogato SN, Westen D. Borderline inpatients with affective disorder: preliminary follow-up data, J Personal Disord 1990;4:213-24.
39. Arboleda-Florez J, Holley HL. Antisocial bumout: an exploratory study. Bulletin of the American Academy of Psychiatry and Law 1991;19:173-83.
40. Harris GT, Rice ME, Cormier CA. Psychopathy and violent recidivism. Law Hum Behav 1991;15:625-37.
41. Mehlum L, Friis S, Irion T, Johns S, Karterud S, Vaglum P, Vaglum S. Personality disorders 2-5 years after treatment: a prospective follow-up study. Acta Psychiatr Scand 1991;84:72-7.
42. Paris J, Zweig-Frank H, Guzder H. The role of psychological risk factors in recovery from borderline personality disorder. Compr Psychiatry 1993;34:410-3.
43. Vaglum P, Friis S, Karterud S, Mehlum L, Vaglum S. Stability of the severe personality disorder diagnosis: a 2- to 5-year prospective study. J Personal Disord 1993;7:348-53.
44. Garnet KE, Levy KN, Mattanah JF, Edell WS, McGlashan TH. Borderline personality disorder in adolescents: ubiquitous or specific? Am J Psychiatry 1994;151:1380-2.
45. Mattanah JJF, Becker DF, Levy KN, Edell WS, McGlashan TH. Diagnostic stability in adolescents followed up 2 years after hospitalization. Am J Psychiatry 1995;152:889-94.
46. Harper TJ, Hare RD. Assessment of psychopathy as a function of age. J Abnorm Psychol 1994;103:604-9.
47. Black DW, Baumgard CH, Bell SE. A 16- to 45-year follow-up of 71 men with antisocial personality disorder. Compr Psychiatry 1995;36:130-40.
48. Najavits L, Gunderson JG. Better than expected: improvements in borderline personality disorder in a 3-year prospective outcome study. Compr Psychiatry 1995;36:296-302.
49. Gunderson JG, Frank AF, Ronningstam EF, Wachter S, Lynch VJ, Wolf PJ. Early discontinuance of borderline patients from psychotherapy. J Nerv Ment Dis 1989;177:38-42.
50. Sabo AN, Gunderson JG. Najavits LM. Changes in self-destructive behavior in borderline patients. J Nerv Ment Dis 1995;183:370-3
51. Ronningstam E, Gunderson J, Lyons M. Changes in pathological narcissism. Am J Psychiatry 1995;152:253-7.
52. American Psychiatric Assocation. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised. Washington (DC): American Psychiatric Press; 1987.
53. Gunderson JG, Kolb JE, Austin V. The diagnostic interview for borderline patients. Am J Psychiatry 1981;138:896-905.
54. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry 1985;42:1081-6.
55. Vilkin MI. Comparative chemotherapeutic trial in treatment of chronic borderline patients. Am J Psychiatry 1964;120:1004.
56. Klein DF. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 1967;16:118-26.
57. Klein DF. Psychiatric diagnosis and typology of clinical drugeffects. Psychopharmacologia 1968;13:359-86.
58. Hedberg DL, Houck JH, Glueck BC. Tranylcypromine-trifluoperazine combination in the treatment of schizophrenia. Arch Gen Psychiatry 1971;127:1141-6.
59. Reyntjens AM. A series of muticentric pilot trials with pimozide in psychiatric practice: part I. Pimozide in the treatment of personality disorders. Acta Psychiatrica Belgica 1972;72:653-61.
60. Rifkin A, Quitkin F, Curillo C, Blumberg AG, Klein DF. Lithium carbonate in emotional unstable character disorder. Arch Gen Psychiatry 1972;27:519-23.
61. Tupin J, Smith D, Clanon T, Kim LI, Nugent A, Groupe A. The long term use of lithium in aggressive prisoners. Compr Psychiatry 1973;14:311-7.
62. Sheard M, Marini J, Bridges C, Wapner A. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-13.
63. Brinkley JR, Beitman BD, Friedel RO. Low-dose neuroleptic regimens in the treatment of borderline patients. Arch Gen Psychiatry 1979;36:319-26.
64. Leone NF. Response of borderline patients to loxapine and chlorpromazine. J Clin Psychiatry 1982;43:148-50.
65. Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 1984;141:1455-8.
66. Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO. Borderline and schizotypal personality disorders treated with low-dose thiothixine versus placebo. Arch Gen Psychiatry 1986;43:680-6.
67. Hymowitz P, Frances AJ, Jacobsberg LB, Sickles M, Hoyt R. Neuroleptic treatment of schizotypal personality disorder. Compr Psychiatry 1986;27:267-71.
68. Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM. Progress in the pharmacotherapy of borderline disorders: a double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 1986;43:691-7.
69. Soloff PH, George A, Nathan RS, Schulz PM, Cornelius JR, Herring J, Perel JM. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989;9:238-46.
70. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988;45:111-9.
71. Norden MJ. Fluoxetine in borderline personality disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1989;13:885-93.
72. Parsons B, Quitkin FM, McGrath PJ, Stewart JW, Tricamo E, Ocepek-Welikson K, and others. Phenelzine, impramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacol Bull 1989;25:524-34.
73. Teicher MH, Glod CA, Aaronson ST, Gunter PA, Schatzbar AF, Cole JO. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder. Psychopharmacol Bull 1989;25:535-49.
74. Coccaro EF, Astill JL, Herbert JL, Schut AG. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorders patients. J Clin Psychopharmacol 1990;10:373-5.
75. Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 1990;26:151-64.
76. Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Personal Disord 1990;4:173-81.
77. Markovitz PJ, Calabrese JR, Schulz SC, Meitzer HY. Fluoxetine treatment of borderline and schizotypal personality disorder. Am J Psychiatry 1991;148:1064-7.
78. Soloff PH, Cornelious J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
79. Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993;34:402-5.
80. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, and others. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1994;15:23-9.
81. Kavoussi RJ, Liu J, Coccaro E. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;5:137-41.
82. Markovitz PJ, Wagner SC. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull 1995;31:773-7.
83. American Psychiatric Assocation. Diagnostic and statistical manual of mental disorders. 2nd ed. Washington (DC): American Psychiatric Press; 1968.
84. Feighner JP, Robins E, Guze SB, Woodruf RA, Winokur G, Munoz R. Diagnositic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
85. Gunderson JG, Kolb JE. Discriminating features of borderline patients. Am J Psychiatry 1978;135:792-6.
86. Soloff PH, George A, Nathan RS, Schulz PM, Perel JM. Paradoxical effects of amitriptyline in borderline patients. Am J Psychiatry 1986;143:1603-5.
87. Argyle M, Bryant BM, Trower P. Social skills training and psychotherapy: a comparative study. Psychol Med 1974;4:435-43.
88. Marzillier JS, Lambert C, Kellen J. A controlled evaluation of systematic desensitization and social skills training for socially inadequate psychiatric patients. Behav Res Ther 1976;14:225-38.
89. Stravynski A, Marks I, Yule W. Social skills problems in neurotic outpatients: social skills training with and without cognitive modification. Arch Gen Psychiatry 1982,39:1378-85.
90. Stravynski A, Grey S, Elie R. An outline of the therapeutic process in social skills training with socially dysfunctional patients. J Consult Clin Psychol 1987;56:224-8.
91. Cappe RF, Alden LE. A comparison of treatment strategies for clients functionally impaired by extreme shyness and social avoidance. J Consult Clin Psychol 1986;54:796-801.
92. Alden L. Short-term structured treatment for avoidant personality disorder. J Consult Clin Psychol 1989;57:756-64.
93. Stravynski A, Belisle M, Marcouiller M, Lavallee Y, Elie R. The treatment of avoidant personality disorder by social skills training in the clinic or real-life settings. Can J Psychiatry 1994;39:377-83.
94. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-4.
95. Linehan MM, Heard HL, Armstrong HE, Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993;50:971-4.
96. Shearin EN, Linehan MM. Patient-therapist ratings and relationship to progress in dialectical behavior therapy for borderline personality disorder. Behavior Therapy 1992;23:730-41.
97. Karterud S, Vaglum S, Friis S, Irion T, Johns S, Vaglum P. Day hospital therapeutic community treatment for patients with personality disorders. J Nerv Ment Dis 1992;180:238-43.
98. Stevenson J, Meares R. An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry 1992;149:358-62.
99. Munroe-Blum H, Marziali E. A controlled trial of short-term group treatment for borderline personality disorder. J Personal Disord 1995;9:190-8.
100. Davidson KM, Tyrer P. Cognitive therapy for antisocial and borderline personality disorders: single case study series. Br J Clin Psychol 1996;35:413-29.
101. Liberman RP, Eckman T. Behavior therapy versus insight-oriented therapy for repeated suicide attempters. Arch Gen Psychiatry 1981;38:1126-30.
102. Pollack J, Winston A, McCullough L, Flegenheimer W, Winston B. Efficacy of brief adaptational psychotherapy. J Personal Disord 1990;4:244-50.
103. Winston A, Pollack J, McCullough L, Flegenheimer W, Kestenbaum R, Trujillo M. Brief psychotherapy of personality disorders. J Nerv Ment Dis 1991;179:188-93.
104. Winston A, Laikin M, Pollack J, Samstag LW, McCullough L, Muran JC. Short-term psychotherapy of personality disorders. Am J Psychiatry 1994;151:190-4.
105. Monsen J, Odland T, Faugli A, Daae E, Eilertsen DE. Personality disorders and psychosocial changes after intensive psychotherapy: a prospective follow-up study of an outpatient psychotherapy project, 5 years after end of treatment. Scand J Psychol 1995;36:256-68.
106. Piper WE, Rosie JS, Joyce AS, Hassan FAA. Time limited day treatment for personality disorders: integration of research and practice in a group program. Washington (DC): American Psychological Association Press; 1996.
107. Springer T, Lohr NE, Buchtel HA, Silk KR. A preliminary report of short-term cognitive-behavioral group therapy for inpatients with personality disorders. J Psychother Pract Res 1996;5:57-71.
108. Benjamin LS. SASB short form user's manual. Salt Lake City (UT): INTREX Interpersonal Institute; 1988.
109. Aveline MO. The limitation of randomized controlled trials as guides to clinical effectiveness with reference to the psychotherapeutic management of neuroses and personality disorders. Current Opinion in Psychiatry 1997;10:113-5.
110. Stone MH. Abnormalities of personality: within and beyond the realm of treatment. New York: Norton; 1993.
111. Paris J. Social factors in the personality disorders: a biopsychosocial approach to etiology and treatment. New York: Cambridge; 1996.
112. Soloff PH. What's new in personality disorders? An update on pharmacologic treatment. J Personal Disord 1990;4:233-43.